Table 2.
Continuous pulse oximetry use in patients with bronchiolitis not receiving any supplemental oxygen or nasal cannula flow.
Unadjusted | Adjustedb | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Variable | Total, n | Continuously monitored with pulse oximetry, n | Continuously monitored with pulse oximetry, % | OR for use of continuous pulse oximetry | 95% CI | Category P value | Composite P valuea | OR for use of continuous pulse oximetry | 95% CI | Category P value | Composite P valuea |
Overall(n=56 hospitals) | 3612 | 1679 | 46 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Age and gestational age categoryc | |||||||||||
8 weeks through 5 months, preterm | 183 | 103 | 56 | 1.78 | 1.12–2.83 | .02 | .11 | 2.58 | 1.65–4.02 | <.001 | <.001 |
8 weeks through 5 months, not preterm | 1559 | 758 | 49 | 1.31 | 1.03–1.66 | .03 | 1.51 | 1.12–2.03 | .007 | ||
6 months through 11 months, preterm | 107 | 47 | 44 | 1.08 | 0.74–1.59 | .68 | 1.21 | 0.72–2.05 | .48 | ||
6 months through 11 months, not preterm | 894 | 402 | 45 | 1.13 | 0.89–1.43 | .31 | 1.26 | 0.93–1.73 | .14 | ||
12 months through 17 months, preterm | 48 | 20 | 42 | 0.99 | 0.52–1.86 | .97 | 0.77 | 0.38–1.58 | .48 | ||
12 months through 17 months, not preterm | 512 | 219 | 43 | 1.03 | 0.74–1.45 | .85 | 1.01 | 0.72–1.42 | .95 | ||
18 months through 23 months, preterm | 23 | 10 | 43 | 1.06 | 0.46–2.47 | .89 | 0.50 | 0.18–1.37 | .18 | ||
18 months through 23 months, not preterm | 286 | 120 | 42 | [reference] | [reference] | ||||||
Sex | |||||||||||
Male | 2125 | 977 | 46 | [reference] | .52 | Not includedb | |||||
Female | 1485 | 702 | 47 | 1.05 | 0.90–1.23 | .52 | |||||
Raced | |||||||||||
White | 2034 | 938 | 46 | [reference] | .61 | Not includedb | |||||
Other | 1025 | 502 | 49 | 1.12 | 0.82–1.53 | .47 | |||||
Black or African American | 553 | 239 | 43 | 0.90 | 0.62–1.28 | .53 | |||||
Ethnicityd | |||||||||||
Not Hispanic or Latino | 2454 | 1088 | 44 | [reference] | .11 | Not includedb | |||||
Hispanic or Latino | 766 | 410 | 54 | 1.45 | 1.05–1.98 | .02 | |||||
Unknown | 259 | 123 | 48 | 1.14 | 0.77–1.68 | .53 | |||||
Other | 133 | 58 | 44 | 0.97 | 0.62–1.51 | .90 | |||||
Time since weaning from supplemental oxygen or flowe | |||||||||||
Never received | 1190 | 442 | 37 | [reference] | <.001 | [reference] | <.001 | ||||
Off < 1 hr | 80 | 59 | 74 | 4.75 | 1.90–11.93 | .001 | 5.01 | 2.76–9.07 | <.001 | ||
Off 1 - < 2 hrs | 148 | 108 | 73 | 4.57 | 2.50–8.35 | <.001 | 5.97 | 3.84–9.30 | <.001 | ||
Off 2 - < 4 hrs | 244 | 166 | 68 | 3.60 | 2.31–5.61 | <.001 | 5.55 | 3.91–7.89 | <.001 | ||
Off 4 - < 6 hrs | 234 | 135 | 58 | 2.31 | 1.49–3.58 | <.001 | 2.96 | 2.13–4.13 | <.001 | ||
Off 6 - < 12 hrs | 505 | 276 | 55 | 2.04 | 1.42–2.93 | <.001 | 2.12 | 1.65–2.72 | <.001 | ||
Off 12 - < 24 hrs | 687 | 302 | 44 | 1.33 | 0.98–1.80 | .07 | 1.16 | 0.93–1.45 | .20 | ||
Off 24 hrs + | 499 | 179 | 36 | 0.95 | 0.68-1-31 | .74 | 0.75 | 0.58–0.97 | .03 | ||
Intensive care unit stay during present hospitalization | |||||||||||
Yes | 884 | 424 | 48 | 1.08 | 0.84–1.39 | .54 | .54 | Not includedb | |||
No | 2728 | 1255 | 46 | [reference] | |||||||
Apnea or cyanosisf | |||||||||||
Yes | 235 | 128 | 54 | 1.41 | 1.07–1.86 | .02 | .02 | 1.40 | 1.01–1.93 | .04 | .04 |
No | 3377 | 1551 | 46 | [reference] | [reference] | ||||||
Comorbid condition associated with neurologic impairmentg | |||||||||||
Yes | 93 | 51 | 55 | 1.41 | 0.96–2.06 | .08 | .08 | 1.50 | 0.93–2.43 | .10 | .10 |
No | 3519 | 1628 | 46 | [reference] | [reference] | ||||||
Enteral feeding tube in placeh | |||||||||||
Yes | 305 | 176 | 58 | 1.64 | 1.23–2.17 | <.001 | <.001 | 1.98 | 1.46–2.67 | <.001 | <.001 |
No | 3307 | 1503 | 45 | [reference] | [reference] | ||||||
Hospital type | |||||||||||
Freestanding (n=33) | 2667 | 1198 | 45 | [reference] | .58 | Not includedb | |||||
Children’s hospital within hospital (n=14) | 591 | 317 | 54 | 1.42 | 0.74–2.73 | .29 | |||||
Community (n=9) | 354 | 164 | 46 | 1.06 | 0.55–2.02 | .86 | |||||
Time of day observation performed | |||||||||||
Day (10AM - 5PM) | 2073 | 870 | 42 | [reference] | <.001 | [reference] | <.001 | ||||
Night (11PM - 7AM) | 1539 | 809 | 53 | 1.53 | 1.27–1.85 | <.001 | 2.07 | 1.76–2.43 | <.001 | ||
Abbreviations: CI, confidence interval; OR, odds ratio.
In variables with multiple categories, composite P-value obtained using Wald test.
The following variables met the pre-specified criteria (see Methods) to be included in the multivariable model: Age and gestational age category, time since weaning from supplemental oxygen or flow, apnea or cyanosis, comorbid condition associated with neurologic impairment, enteral feeding tube in place, and time of day observation performed. Ethnicity met initial criteria to enter the model based on having a bivariable association composite P value <.2 but was eliminated from the multivariable model for a composite P value of .34.
Not preterm included the following: documented gestational age 34 0/7 weeks and above, or absence of gestational age but documented as full term, or absence of gestational age but not labeled in chart as preterm or premature.
Patient family-reported race and ethnicity were abstracted from charts in categories defined by the Standards for the Classification of Federal Data on Race and Ethnicity, in compliance with NIH inclusion reporting policies. In this Table, “Other” race combines all of the following categories: American Indian or Alaska Native, Asian, Native Hawaiian or Pacific Islander, specified as more than one race, specified as other, specified as unknown.
Unknown time since weaning (n=25) excluded from Table.
Includes documentation of apnea or cyanosis occurring at home or in hospital during the present illness.
Static encephalopathy, cerebral palsy, hydrocephalus, spina bifida, epilepsy/seizure disorder, or hypotonia.
Nasogastric or gastrostomy.